ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag calorie restriction disease medicine evolution

Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Running on Empty
Bob Grant | Jun 1, 2017 | 10+ min read
Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.
Longevity
Jill Adams(juadams@the-scientist.com) | May 8, 2005 | 7 min read
During autophagy-literally "self-eating"-cells deliver cytoplasmic constituents, including whole organelles, to the lysosome for degradation.
Notebook
The Scientist Staff | Oct 26, 1997 | 7 min read
Table of Contents Priviledged Information The Appeal of Creation Hungry for Life Petit Moues Model Women in Trials Keep on Smiling New-Look FDA? The United States Securities and Exchange Commission (SEC) filed an insider trading complaint against a Columbia University professor on September 28. The complaint names Dale J. Lange, a professor of neurology at Columbia's College of Physicians and Surgeons, and six others for trading in Cephalon Inc. securities prior to the West Chester, Pa.-base
The Longevity Dividend
S. Jay Olshansky, Daniel Perry, Richard A. Miller, Robert N. Butler | Mar 1, 2006 | 10+ min read
FEATUREThe Longevity Dividend Redrawn from Koloman Moser's Frommes KalendarIllustrations by Joelle Boltan intervention, such as a pill, that could significantly reduce your risk of cancer. Imagine an intervention that could reduce your risk of stroke, or dementia, or arthritis. Now, imagine an intervention that does all these things, and at the same time reduces your risk of everything else undesirable about growing older: inc
Top 10 Innovations 2014
The Scientist | Dec 1, 2014 | 10+ min read
The list of the year’s best new products contains both perennial winners and innovative newcomers.
Re-engineering Humans
The Scientist | Mar 1, 2007 | 10+ min read
We challenged experts across fields to imagine a new way to solve the problems of human aging. Our question: What if Humans were Designed to Last? By S. Jay Olshansky, Robert N. Butler, and Bruce A. Carnes Illustrations by Thom Graves When Michelangelo painted The Creation of Adam on the ceiling of the Sistine Chapel, he portrayed the Renaissance view of humanity as having been molded by the hand of its creator, a "perfect" physical spe
Researchers Receiving MacArthur Fellowships Demonstrate 'Capacity To Make A Difference'
Bruce Anderson | Sep 14, 1997 | 6 min read
PRIZE WITH A PRICE: Science historian Peter Galison has taken some ribbing from his family since being named a MacArthur fellow. One could almost pity Peter Galison. A historian of science at Harvard University, Galison is one of seven members of the scientific community among the 23 recipients of this year's John D. and Catherine T. MacArthur Foundation Fellowships. The coveted five-year awards provide unrestricted support plus health insurance to talented individuals, with no reports or proj
Soybeans Hit Main Street
Barry Palevitz | Mar 19, 2000 | 8 min read
Once a favorite of Chinese emperors, tofu is now big time. From supermarkets to health food boutiques, diet-conscious Americans are buying soybeans, not just as tofu but in infant formula, soy milk, and soy burgers. Soy even has the Food and Drug Administration's seal of approval. Last October the FDA responded to a petition by Protein Technologies International, a St. Louis-based DuPont company specializing in soy products, by authorizing claims that soy protein is good for the heart. Acc

Run a Search

ADVERTISEMENT